Literature DB >> 12933919

The prevalence and causes of dementia in people under the age of 65 years.

R J Harvey1, M Skelton-Robinson, M N Rossor.   

Abstract

OBJECTIVES: To determine the prevalence of dementia in people under the age of 65 in a large catchment area, and use these figures to estimate the number of younger people affected by dementia in the UK.
DESIGN: Epidemiological catchment area prevalence survey.
SETTING: The London boroughs of Kensington and Chelsea, Westminster, and Hillingdon with a total population of 567500 people. PARTICIPANTS: All residents of the catchment area with dementia, where the illness began before the age of 65 years. Participants were notified to the study by medical and care professionals. The diagnosis and age of onset was established from all available health and social care records. In total, 227 people were identified, of whom 185 fulfilled the inclusion criteria of having a dementia which started before their 65th birthday. MAIN OUTCOME MEASURES: Diagnosis of dementia and differential diagnosis of the cause of the dementia.
RESULTS: The prevalence of dementia in those aged 30-64 was 54.0 per 100000 (95% CI 45.1 to 64.1 per 100000). For those aged 45-64 years, the prevalence was 98.1 per 100000 (95% CI 81.1 to 118.0 per 100000). From the age of 35 onwards, the prevalence of dementia approximately doubled with each 5 year increase in age. Extrapolating these figures nationally suggests that there are 18319 (15296-21758) people with dementia under the age of 65 in the UK.
CONCLUSIONS: The study confirms previous "guestimates" of the number of younger people affected by dementia in UK. The prevalence figures generated are robust, and are supported by other smaller and targeted prevalence surveys. The prevalence figures provided by this study will allow health planners to accurately estimate need and plan services.

Entities:  

Mesh:

Year:  2003        PMID: 12933919      PMCID: PMC1738690          DOI: 10.1136/jnnp.74.9.1206

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

Review 1.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Authors:  I G McKeith; D Galasko; K Kosaka; E K Perry; D W Dickson; L A Hansen; D P Salmon; J Lowe; S S Mirra; E J Byrne; G Lennox; N P Quinn; J A Edwardson; P G Ince; C Bergeron; A Burns; B L Miller; S Lovestone; D Collerton; E N Jansen; C Ballard; R A de Vos; G K Wilcock; K A Jellinger; R H Perry
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

2.  The diagnosis of dementia in the elderly. A comparison of CAMCOG (the cognitive section of CAMDEX), the AGECAT program, DSM-III, the Mini-Mental State Examination and some short rating scales.

Authors:  G Blessed; S E Black; T Butler; D W Kay
Journal:  Br J Psychiatry       Date:  1991-08       Impact factor: 9.319

3.  Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.

Authors:  B Reisberg; J Borenstein; S P Salob; S H Ferris; E Franssen; A Georgotas
Journal:  J Clin Psychiatry       Date:  1987-05       Impact factor: 4.384

4.  Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88.

Authors:  G McGonigal; B Thomas; C McQuade; J M Starr; W J MacLennan; L J Whalley
Journal:  BMJ       Date:  1993-03-13

5.  Identification of underprivileged areas.

Authors:  B Jarman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

6.  Assessing the severity of dementia. Patient and caregiver.

Authors:  S Teunisse; M M Derix; H van Crevel
Journal:  Arch Neurol       Date:  1991-03

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975.

Authors:  E Kokmen; C M Beard; K P Offord; L T Kurland
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

9.  Clinically diagnosed presenile dementia of the Alzheimer type in the Northern Health Region: ascertainment, prevalence, incidence and survival.

Authors:  A J Newens; D P Forster; D W Kay; W Kirkup; D Bates; J Edwardson
Journal:  Psychol Med       Date:  1993-08       Impact factor: 7.723

10.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

View more
  149 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

Review 2.  Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Authors:  Margaret Flanagan; Eric B Larson; Caitlin S Latimer; Brenna Cholerton; Paul K Crane; Kathleen S Montine; Lon R White; C Dirk Keene; Thomas J Montine
Journal:  Biochim Biophys Acta       Date:  2015-08-28

3.  Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.

Authors:  E Gordon; J D Rohrer; L G Kim; R Omar; M N Rossor; N C Fox; J D Warren
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

4.  Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43.

Authors:  Antonella Caccamo; Smita Majumder; Salvatore Oddo
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 5.  Epidemiology and risk factors of dementia.

Authors:  W M van der Flier; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

6.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.

Authors:  Deepak M Sampathu; Manuela Neumann; Linda K Kwong; Thomas T Chou; Matthew Micsenyi; Adam Truax; Jennifer Bruce; Murray Grossman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

7.  Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).

Authors:  D Porquet; P Andrés-Benito; C Griñán-Ferré; A Camins; I Ferrer; A M Canudas; J Del Valle; Mercè Pallàs
Journal:  Age (Dordr)       Date:  2015-02-08

Review 8.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 9.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

10.  Cognitive and noncognitive neurological features of young-onset dementia.

Authors:  Brendan J Kelley; Bradley F Boeve; Keith A Josephs
Journal:  Dement Geriatr Cogn Disord       Date:  2009-07-11       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.